Synairgen (SNG) News Today GBX 2 -1.75 (-46.60%) (As of 12/20/2024 12:01 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Synairgen Leads The Charge With 2 Other Promising Penny Stocks On UK ExchangeDecember 11, 2024 | uk.finance.yahoo.comBioventix PLC (BVXP.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comSynairgen Share Chat (SNG)September 17, 2024 | lse.co.ukBnpp Easy Eur Corp Sri Fossil Free 7-10y Share Price (SRID7.PA)September 8, 2024 | lse.co.ukDeliveroo announces new buyback as achieves first half profitAugust 10, 2024 | lse.co.ukVodafone-Three merger delayed further as watchdog extends probeAugust 2, 2024 | lse.co.ukLONDON MARKET MIDDAY: US recession fears dampen mood ahead of payrollsAugust 2, 2024 | lse.co.ukSuominen Ord Share ChatMay 27, 2024 | lse.co.ukPrimorus Inv. Share ChatMay 22, 2024 | lse.co.ukSonagi SGPS SA SNGApril 4, 2024 | morningstar.comSynairgen plc (SYGGF) Stock Historical Prices & Data - Yahoo FinanceFebruary 8, 2024 | finance.yahoo.comSynairgen plc (SNG.L)February 7, 2024 | uk.finance.yahoo.comCompanies Like Synairgen (LON:SNG) Are In A Position To Invest In GrowthJanuary 22, 2024 | finance.yahoo.comSynairgen PLC SYGGFDecember 23, 2023 | morningstar.comSynairgen PLC OMYDecember 16, 2023 | morningstar.comSynairgen PLC SNGDecember 16, 2023 | morningstar.comSNGN Romgaz SA SNGNovember 22, 2023 | morningstar.comSynairgen Finance Chief John Ward Steps Down; Colliver Named as ReplacementOctober 11, 2023 | marketwatch.comSynairgen appoints new CFO as incumbent bows out after nearly 20 yearsOctober 11, 2023 | proactiveinvestors.comSynairgen takes targeted approach with lead assetSeptember 21, 2023 | proactiveinvestors.comSynairgen looking beyond COVID in fight against respiratory illnessSeptember 21, 2023 | finance.yahoo.comWe Think Synairgen (LON:SNG) Needs To Drive Business Growth CarefullyJune 13, 2023 | finance.yahoo.comSNG.L - Synairgen plcJune 9, 2023 | finance.yahoo.comCompanies Like Synairgen (LON:SNG) Could Be Quite RiskyJanuary 4, 2023 | finance.yahoo.comFTSE 100 jumps 140 points as L&G statement reassures - Proactive Investors USAOctober 4, 2022 | proactiveinvestors.comSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19October 4, 2022 | finance.yahoo.comSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19 - Business WireOctober 4, 2022 | businesswire.comSynairgen Shares Drop Amid Phase 3 Study Issues; Pretax Loss Narrows - MarketWatchSeptember 30, 2022 | marketwatch.comEARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens | Financial News - London South EastSeptember 29, 2022 | lse.co.ukTesla appoints Airbnb co-founder Joe Gebbia to board - Proactive Investors USASeptember 29, 2022 | proactiveinvestors.comSynairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022September 20, 2022 | finance.yahoo.comSynairgen's SNG001 Reduces Long COVID-19 Symptoms In Follow-up Visits After Late-stage Trial - Marketscreener.comSeptember 20, 2022 | marketscreener.comSynairgen to present data showing drug lowers risk of long Covid symptoms - Proactive Investors USASeptember 20, 2022 | proactiveinvestors.comIN BRIEF: Synairgen shares rise as positive data found for COPD | Financial News - London South EastSeptember 7, 2022 | lse.co.ukSynairgen announces positive findings from analysis of lung samples from the SG015 trial of SNG001 in virally infected COPD patientsSeptember 7, 2022 | finance.yahoo.comSynairgen unveils positive clinical trial data | Financial News - London South EastSeptember 7, 2022 | lse.co.ukSynairgen Gets Positive Data From Trial of Respiratory Drug Treatment - MarketWatchSeptember 7, 2022 | marketwatch.comSynairgen reports positive data from respiratory viral infection drug - Proactive Investors USASeptember 7, 2022 | proactiveinvestors.comFTSE 100 opens lower as oil giants push ahead - Proactive Investors USASeptember 5, 2022 | proactiveinvestors.comTRADING UPDATES: Bradda wins drilling approval; Oakley invests in vLex - MorningstarSeptember 5, 2022 | morningstar.co.ukSynairgen to play key role in respiratory viral infection study - Proactive Investors USASeptember 5, 2022 | proactiveinvestors.comThe Synairgen share price crashes again as US study is haltedAugust 5, 2022 | fool.co.ukChronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswireJune 29, 2022 | globenewswire.comCan Synairgen (LON:SNG) Afford To Invest In Growth?May 31, 2022 | finance.yahoo.comIN BRIEF: Synairgen shares fall as loss widens on higher costs - MorningstarMay 27, 2022 | morningstar.co.ukIN BRIEF: Synairgen shares fall as loss widens on higher costs | Financial News - London South EastMay 25, 2022 | lse.co.ukSynairgen "working in haste" to plan new lung infection trials - Proactive Investors USAMay 25, 2022 | proactiveinvestors.comSynairgen PLC on presenting at the ATS conference in San FranciscoMay 19, 2022 | ca.proactiveinvestors.comSynairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022 - Business WireMay 16, 2022 | businesswire.comSynairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022May 16, 2022 | finance.yahoo.com Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW SNG Media Mentions By Week SNG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNG News Sentiment▼0.000.60▲Average Medical News Sentiment SNG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNG Articles This Week▼00▲SNG Articles Average Week Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies C4X Discovery News Today Sareum News Today Arecor Therapeutics News Today Ondine Biomedical News Today OptiBiotix Health News Today Oncimmune News Today Fusion Antibodies News Today IXICO News Today ImmuPharma News Today Oxford BioDynamics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SNG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
